248
Participants
Start Date
April 2, 2024
Primary Completion Date
October 15, 2025
Study Completion Date
December 10, 2025
Survodutide
Survodutide
Placebo
Placebo matching survodutide
Hospital Clínic de Barcelona, Barcelona
GI Select Health Research LLC, Richmond
Hospital Ramón y Cajal, Madrid
Hospital La Paz, Madrid
Medical University of South Carolina, Charleston
Fleming Island Center for Clinical Research, Fleming Island
Velocity Clinical Research-Hallandale Beach-67888, Hallandale
Panax Clinical Research, Miami Lakes
Verus Clinical Research Corporation, Miami
Excel Medical Clinical Trials, Boca Raton
Health Awareness, Inc., Jupiter
Segal Drug Trials, Delray Beach
Covenant Metabolic Specialists, LLC-Fort Myers-69019, Fort Myers
Covenant Research and Clinics, LLC, Sarasota
Nature Coast Clinical Research-Inverness-48221, Inverness
DSI Research Northridge LLC, Dayton
Indiana University, Indianapolis
University of Iowa Hospitals and Clinics, Iowa City
Springfield Clinic, LLP, Springfield
Washington University School of Medicine, St Louis
Kansas Medical Center, Topeka
Louisiana Research Center, LLC, Shreveport
Velocity Clinical Research, Waco, Waco
Gastroenterology and Liver Research LLC, Houston
Biopharma Informatic, Inc. Research Center, Houston
Accurate Clinical Research, Inc., Humble
Clinical Trials of Texas, LLC, San Antonio
Amel Med LLC, Georgetown
Velocity Clinical Research, Austin, Austin
Velocity Clinical Research-Gardena-69773, Gardena
Velocity Clinical Research-Panorama City-68861, Panorama City
Velocity Clinical Research-North Hollywood-69852, North Hollywood
Catalina Research Institute, LLC-Montclair-69754, Montclair
ARK Clinical Research, Long Beach
Velocity Clinical Research-Santa Ana-68902, Santa Ana
ARK Clinical Research, Fountain Valley
Hospital Vall d'Hebron, Barcelona
Lead Sponsor
Boehringer Ingelheim
INDUSTRY